Han-Jie Zhou Selected Research

ATPases Associated with Diverse Cellular Activities

1/2021	Targeting acute myeloid leukemia dependency on VCP-mediated DNA repair through a selective second-generation small-molecule inhibitor.
11/2017	The p97 Inhibitor CB-5083 Is a Unique Disrupter of Protein Homeostasis in Models of Multiple Myeloma.
11/2015	Targeting the AAA ATPase p97 as an Approach to Treat Cancer through Disruption of Protein Homeostasis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Han-Jie Zhou Research Topics

Disease

6	Neoplasms (Cancer) 01/2019 - 05/2009
2	Multiple Myeloma 11/2017 - 05/2009
1	Ataxia Telangiectasia (Louis Bar Syndrome) 01/2021
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2021
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 05/2009

Drug/Important Bio-Agent (IBA)

3	ATPases Associated with Diverse Cellular ActivitiesIBA 01/2021 - 11/2015
2	Adenosine Triphosphatases (ATPase)IBA 01/2021 - 01/2019
2	CB-5083IBA 11/2017 - 11/2015
2	Proteasome Endopeptidase Complex (Proteasome)IBA 11/2017 - 05/2009
1	Phosphotransferases (Kinase)IBA 01/2021
1	Small Interfering RNA (siRNA)IBA 01/2021
1	Valosin Containing ProteinIBA 01/2021
1	UbiquitinIBA 11/2017
1	Proteasome InhibitorsIBA 11/2017
1	Ubiquitinated ProteinsIBA 11/2015
1	KinesinsIBA 04/2010
1	carfilzomibIBA 05/2009

Therapy/Procedure

2	Oral Administration 12/2015 - 05/2009